Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance-Reference-Cited by-同舟云学术

Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance

Published:2018-06-14 Issue:6 Volume:19 Page:1765
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Nguyen Ha,Shabani Saman,Awad Ahmed,Kaushal Mayank^ORCID,Doan Ninh

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/6/1765/pdf

Reference121 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010

2. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

3. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011

4. Epidemiology of Brain Tumors

5. Genetics of adult glioma

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review;Cancer Chemotherapy and Pharmacology;2024-06-25

2. Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study;Cancer Letters;2024-04

3. GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment;Experimental Hematology & Oncology;2024-01-31

4. Integrative analysis of transcriptome and proteome profiles in primary and recurrent glioblastoma;PROTEOMICS – Clinical Applications;2023-12

5. The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive;International Journal of Molecular Sciences;2023-10-23